You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

ATROPINE SULFATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Atropine Sulfate patents expire, and when can generic versions of Atropine Sulfate launch?

Atropine Sulfate is a drug marketed by Us Army, Amneal, Apotex, Bausch And Lomb Inc, Mankind Pharma, Rising, Accord Hlthcare, Am Regent, Hospira, Intl Medication Sys, Medefil Inc, Fresenius Kabi Usa, and Hikma. and is included in sixteen NDAs.

The generic ingredient in ATROPINE SULFATE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Atropine Sulfate

A generic version of ATROPINE SULFATE was approved as atropine sulfate by HOSPIRA on July 9th, 2001.

  Try a Trial

Summary for ATROPINE SULFATE
Drug patent expirations by year for ATROPINE SULFATE
Recent Clinical Trials for ATROPINE SULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical LimitedPhase 1
Shandong University of Traditional Chinese MedicineN/A
Shanghai Eye Disease Prevention and Treatment CenterN/A

See all ATROPINE SULFATE clinical trials

US Patents and Regulatory Information for ATROPINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army ATROPINE SULFATE atropine sulfate AEROSOL, METERED;INHALATION 020056-001 Sep 19, 1990 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira ATROPINE SULFATE atropine sulfate SOLUTION;INTRAVENOUS 021146-003 Jul 9, 2001 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Accord Hlthcare ATROPINE SULFATE atropine sulfate SOLUTION;INTRAVENOUS 212868-001 Jul 26, 2021 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch And Lomb Inc ATROPINE SULFATE atropine sulfate SOLUTION/DROPS;OPHTHALMIC 213581-001 Mar 15, 2022 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Am Regent ATROPINE SULFATE atropine sulfate SOLUTION;INTRAVENOUS 216120-001 May 26, 2022 AP RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.